Subconjunctival injection of mesenchymal stromal cells protects the cornea in an experimental model of GVHD.

CONCLUSIONS: The treatment with hMSCs by subconjunctival injection is effective in reducing corneal inflammation and squamous metaplasia in ocular GVHD (oGVHD). Local treatment with hMSCs is a promising strategy for oGVHD.
PMID: 30630121 [PubMed - as supplied by publisher]

Source: The Ocular Surface - January 7, 2019 Category: Opthalmology Authors: Martínez-Carrasco R, Sánchez-Abarca LI, Nieto-Gómez C, García EM, Sánchez-Guijo F, Argüeso P, Aijón J, Hernández-Galilea E, Velasco A Tags: Ocul Surf Source Type: research